logo

FDA Calendar

Share
Company Name Apellis Pharmaceuticals, Inc.
Drug Name Pegcetacoplan (NDA)
Event Name FDA decision on Pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)
Event Date 05/14/2021
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar